XWELL INC
XWELNASDAQTrading Snapshot
- Day Range
- $0.89 β $0.91
- 52-Week Range
- $0.26 β $2.20
- Volume
- $2.01B
- Avg Volume
- $1.95B
- Shares Outstanding
- 8.4M
- Next Earnings
- Nov 4, 2026
Fundamentals Snapshot
- Annual Revenue
- $29M
- Last Q Revenue
- $7M
- P/E Ratio
- β
- P/S Ratio
- 0.3x
- EPS (TTM)
- $-3.51
- Dividend Yield
- β
- Dilution (1yr)
- +10.1%
Why Investors Own XWEL
- βHigh-growth profile β revenue up -7.5% YoY with expanding US Equity exposure.
- βHealthy economics β 42% gross margin and 9% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
XWELL INC
XWELAbout XWELL INC
XWELL Inc. functions as a health and wellness services provider, primarily operating within airports. The company delivers its diverse offerings through various brands, including XpresSpa, XpresTest, Treat, and HyperPointe. Its core services feature a range of spa treatments such as massages, nail care, and skincare, further complemented by the sale of spa, travel, and general retail merchandise. Beyond relaxation services, XWELL also manages dedicated wellness centers. These facilities provide crucial health diagnostic services, encompassing COVID-19 screening and testing, rapid tests for various communicable diseases like influenza, RSV, and different flu strains (A&B), alongside seasonal flu vaccinations and other medical diagnostic procedures. To enhance accessibility for the traveling public, the company utilizes an integrated digital platform and a tailored retail selection. As of December 31, 2021, XWELL maintained a significant global presence, with 52 spa and clinic locations spanning 24 airports across the United States, the Netherlands, and the United Arab Emirates. The organization, headquartered in New York, New York, underwent a name change in October 2022, transitioning from its former identity as XpresSpa Group, Inc. to its current designation, XWELL Inc.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Analyst Price Target
βLatest News & Updates
XWELL INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift XWEL price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
XWELL INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.